Literature DB >> 33681460

Prediction of Disease Free Survival in Laryngeal and Hypopharyngeal Cancers Using CT Perfusion and Radiomic Features: A Pilot Study.

Sean Woolen1, Apurva Virkud1, Lubomir Hadjiiski1, Kenny Cha1, Heang-Ping Chan1, Paul Swiecicki2, Francis Worden2, Ashok Srinivasan1.   

Abstract

(1) Purpose: The objective was to evaluate CT perfusion and radiomic features for prediction of one year disease free survival in laryngeal and hypopharyngeal cancer. (2) Method and Materials: This retrospective study included pre and post therapy CT neck studies in 36 patients with laryngeal/hypopharyngeal cancer. Tumor contouring was performed semi-autonomously by the computer and manually by two radiologists. Twenty-six radiomic features including morphological and gray-level features were extracted by an internally developed and validated computer-aided image analysis system. The five perfusion features analyzed included permeability surface area product (PS), blood flow (flow), blood volume (BV), mean transit time (MTT), and time-to-maximum (Tmax). One year persistent/recurrent disease data were obtained following the final treatment of definitive chemoradiation or after total laryngectomy. We performed a two-loop leave-one-out feature selection and linear discriminant analysis classifier with generation of receiver operating characteristic (ROC) curves and confidence intervals (CI). (3)
Results: 10 patients (28%) had recurrence/persistent disease at 1 year. For prediction, the change in blood flow demonstrated a training AUC of 0.68 (CI 0.47-0.85) and testing AUC of 0.66 (CI 0.47-0.85). The best features selected were a combination of perfusion and radiomic features including blood flow and computer-estimated percent volume changes-training AUC of 0.68 (CI 0.5-0.85) and testing AUC of 0.69 (CI 0.5-0.85). The laryngoscopic percent change in volume was a poor predictor with a testing AUC of 0.4 (CI 0.16-0.57). (4) Conclusions: A combination of CT perfusion and radiomic features are potential predictors of one-year disease free survival in laryngeal and hypopharyngeal cancer patients.
© 2021 by the authors.

Entities:  

Keywords:  AT-101; CT perfusion; laryngeal cancer; radiomics

Mesh:

Year:  2021        PMID: 33681460      PMCID: PMC7934704          DOI: 10.3390/tomography7010002

Source DB:  PubMed          Journal:  Tomography        ISSN: 2379-1381


  14 in total

1.  Improvement of mammographic mass characterization using spiculation meausures and morphological features.

Authors:  B Sahiner; H P Chan; N Petrick; M A Helvie; L M Hadjiiski
Journal:  Med Phys       Date:  2001-07       Impact factor: 4.071

2.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

Authors:  Arlene A Forastiere; Helmuth Goepfert; Moshe Maor; Thomas F Pajak; Randal Weber; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; Clifford Chao; Glen Peters; Ding-Jen Lee; Andrea Leaf; John Ensley; Jay Cooper
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

3.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

4.  Computer-aided diagnosis of pulmonary nodules on CT scans: segmentation and classification using 3D active contours.

Authors:  Ted W Way; Lubomir M Hadjiiski; Berkman Sahiner; Heang-Ping Chan; Philip N Cascade; Ella A Kazerooni; Naama Bogot; Chuan Zhou
Journal:  Med Phys       Date:  2006-07       Impact factor: 4.071

5.  Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy.

Authors:  M T Truong; N Saito; A Ozonoff; J Wang; R Lee; M M Qureshi; S Jalisi; O Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

Review 6.  Laryngeal neurophysiology and its clinical uses.

Authors:  G E Woodson
Journal:  Head Neck       Date:  1996 Jan-Feb       Impact factor: 3.147

Review 7.  Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer.

Authors:  Jeffrey M Vainshtein; Vivian F Wu; Matthew E Spector; Carol R Bradford; Gregory T Wolf; Francis P Worden
Journal:  Expert Rev Anticancer Ther       Date:  2013-09       Impact factor: 4.512

8.  Head and neck cancers on CT: preliminary study of treatment response assessment based on computerized volume analysis.

Authors:  Lubomir Hadjiiski; Suresh K Mukherji; Mohannad Ibrahim; Berkman Sahiner; Sachin K Gujar; Jeffrey Moyer; Heang-Ping Chan
Journal:  AJR Am J Roentgenol       Date:  2010-04       Impact factor: 3.959

9.  Bladder Cancer Treatment Response Assessment in CT using Radiomics with Deep-Learning.

Authors:  Kenny H Cha; Lubomir Hadjiiski; Heang-Ping Chan; Alon Z Weizer; Ajjai Alva; Richard H Cohan; Elaine M Caoili; Chintana Paramagul; Ravi K Samala
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

10.  Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy.

Authors:  Lokesh Rana; Sanjiv Sharma; Shikha Sood; Balraj Singh; Manoj K Gupta; R S Minhas; Anupam Jhobta; Vikas Bhatia; Bargavee Venkat
Journal:  Eur J Radiol Open       Date:  2015-03-17
View more
  2 in total

1.  Nursing Observation on the Clinical Efficacy and Toxicity of Lobaplatin Compared with Cisplatin in the Treatment of Locally Advanced Hypopharyngeal Carcinoma Based on Intelligent CT Imaging.

Authors:  Yunyan Li; Guangrun Yang; Mengmeng Li; Xu Tong
Journal:  J Healthc Eng       Date:  2021-06-30       Impact factor: 2.682

Review 2.  Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review.

Authors:  T H Perik; E A J van Genugten; E H J G Aarntzen; E J Smit; H J Huisman; J J Hermans
Journal:  Abdom Radiol (NY)       Date:  2021-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.